Feasibility of Treating Adults with Ewing or Ewing‐Like Sarcoma with Interval‐Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide

BACKGROUND: Vincristine, doxorubicin, and cyclophosphamide (VDC) alternating with ifosfamide and etoposide (IE) administered every 2 weeks demonstrated a superior event‐free survival compared with 3‐week dosing in a landmark pediatric trial and is now standard of care for younger patients. Only 12%...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Lu, Eric, Ryan, Christopher W., Bassale, Solange, Lim, Jeong Youn, Davis, Lara E.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2019
Schlagworte:
Sarcomas
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011630/
https://ncbi.nlm.nih.gov/pubmed/32043790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0532
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge